Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Andrew David Zelenetz, Nishitha Reddy, Deepa Jagadeesh, Anastasios Stathis, Huda S. Salman, Jacob D. Soumerai, Vaishalee Padgaonkar Kenkre, Adam Steven Asch, Judith Llorin-Sangalang, Joanne Li, Igor Gorbatchevsky, John M. Pagel | ||||||||||||
Title | Tolerability and durable respones of the PI3Kδ inhibitor ME-401 administered on an intermittent schedule in relapsed/refractory (R/R) follicular lymphoma (FL) and other B-cell malignancies. | ||||||||||||
|
|||||||||||||
URL | https://meetinglibrary.asco.org/record/186023/abstract | ||||||||||||
Abstract Text | J Clin Oncol 38: 2020 (suppl; abstr 8016), DOI: 10.1200/JCO.2020.38.15_suppl.8016 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|